News

Gladstone in the News May 18, 2020

Coronavirus: Trump Predicts Vaccine Delivery by End of 2020. Experts Say That’s Not Likely.

The Mercury News—Scientists are racing to develop and test vaccines to protect people against COVID-19, and clinical trials to determine the efficacy of one leading vaccine candidate are scheduled to begin in July. Melanie Ott, director of the Gladstone Institute of Virology, explained that vaccine development is a lengthy process, and the development of effective therapeutics may come before a vaccine is widely available.

Gladstone Experts COVID-19 Virology Ott Lab

Article May 12, 2020

This Is Philanthropy’s Time: How Donors Are Providing Urgent Funding to End the Pandemic

As Gladstone scientists are moving to study COVID-19, urgent funding is needed to support their efforts.

Donor Stories COVID-19 Virology Ott Lab

Article May 12, 2020

Commuting to the Lab during a Pandemic: Meet the Scientists Who Are Studying COVID-19

While many are working from home, these scientists are continuing to go to the lab in hopes of making a discovery that could lead to the end of the COVID-19 pandemic.

Gladstone Experts Graduate Students and Postdocs COVID-19 Cardiovascular Disease Data Science and Biotechnology Virology Conklin Lab McDevitt Lab Ott Lab

Gladstone in the News May 12, 2020

SF’s Gladstone Institutes Splits Research Work in Battle against Coronavirus, Future Diseases

San Francisco Chronicle—Gladstone announced the formation of two new institutes that will shape the future of infectious disease research. Senior Investigator Melanie Ott with take the helm of the newly formed Gladstone Institute of Virology, and Senior Investigator Alexander Marson will direct the Gladstone-UCSF Institute of Genomic Immunology.

Institutional News Genomic Immunology Virology Marson Lab Ott Lab

Gladstone in the News May 8, 2020

New Gladstone Institutes Point to Emerging Concepts in Virology, Immunology

Biocentury—Gladstone announced the formation of two new institutes: the Gladstone Institute of Virology, which will focus on COVID-19 and other emerging viruses, and the Gladstone-UCSF Institute of Genomic Immunology, which will focus on approaches to manipulate the immune system to fight cancer, autoimmune disease, and infectious disease.

Institutional News Genomic Immunology Virology Marson Lab Ott Lab

Gladstone in the News May 8, 2020

Scientists at Gladstone and UCSF Form Two New Research Institutes

The Stem Cellar—Gladstone announced the formation of two new institutes: the Gladstone Institute of Virology, which will focus on COVID-19 and other emerging viruses, and the Gladstone-UCSF Institute of Genomic Immunology, which will focus on approaches to manipulate the immune system to fight cancer, autoimmune disease, and infectious disease. The Institute of Virology will be led by Melanie Ott, and the Institute of Genomic Immunology will be led by Alexander Marson.

Institutional News Genomic Immunology Virology Marson Lab Ott Lab

Gladstone in the News May 7, 2020

Gladstone Launches Two New Institutes: One Focused on COVID-19, the Other on Cell Therapies

San Francisco Business Times—Gladstone recently announced the formation of two new institutes: the Gladstone Institute of Virology, which will be directed by Melanie Ott, and the Gladstone-UCSF Institute of Genomic Immunology, which will be led by Alexander Marson.

Institutional News Genomic Immunology Virology Marson Lab Ott Lab

Article May 7, 2020

Two New Research Institutes in the Bay Area

Scientists at Gladstone and UCSF launch new efforts in virology and genomic immunology

Institutional News News Release Genomic Immunology Virology Greene Lab Marson Lab Ott Lab

Gladstone in the News April 30, 2020

Gladstone Institutes Researchers Tackle Coronavirus with Robotics, Mobile Phone Technology

Engineering.com—Gladstone Senior Investigators Melanie Ott and Jennifer Doudna are collaborating with scientists across the Bay Area to develop a rapid COVID-19 testing platform that pairs CRISPR technology with a smartphone camera.

Gladstone Experts COVID-19 Data Science and Biotechnology Virology Doudna Lab Ott Lab CRISPR/Gene Editing

Article April 24, 2020

From HIV to COVID-19

Researchers who spent decades studying human immunodeficiency virus are using some of the same tools and approaches to tackle SARS-CoV-2, the virus that causes COVID-19.

Gladstone Experts COVID-19 HIV/AIDS Center for HIV Cure Research Virology Akassoglou Lab Doudna Lab Greene Lab Ott Lab

Gladstone in the News April 17, 2020

The Promise and Peril of Antibody Testing for COVID-19

JAMA Network—Antibody tests could help identify who has already been infected with SARS-CoV-2, and may now be immune. Gladstone Investigator Melanie Ott explains that understanding how far immunity has spread could help determine when it will be safe to ease social distancing requirements.

Gladstone Experts COVID-19 Virology Ott Lab

Gladstone in the News April 14, 2020

To Accelerate Innovation, the CDC Should Ease Limits on Which Labs Can Handle the Coronavirus

STAT News—The Centers for Disease Control and Prevention currently requires that research on SARS-CoV-2, the virus that causes COVID-19, be conducted in special biosafety level 3 labs (BSL-3). Senior Investigator Melanie Ott explains why that requirement could slow down research progress.

Gladstone Experts COVID-19 Ott Lab

Gladstone in the News April 9, 2020

You Need a Special Lab to Study the Coronavirus. Here’s What It Takes to Get One up and Running.

STAT News—Gladstone Investigator Melanie Ott describes what’s necessary to set up a biosafety level 3 lab (BSL-3) for research on live coronavirus.

Gladstone Experts Research (Publication) COVID-19 Ott Lab

Gladstone in the News April 8, 2020

The Best Hopes for a Coronavirus Drug

The Atlantic—The coronavirus has only 29 proteins. How is it possible that so few amounts can wreak havoc with the tens of thousands of healthy proteins in our bodies?

COVID-19 Virology Ott Lab

Gladstone in the News April 6, 2020

Scientists around the Globe Pivot Their Research to SARS-CoV-2

The Scientist—Gladstone researchers quickly pivot to work to get SARS-CoV-2 research up and running. The Ott Lab is relying on previously established lung organoids to test the effects of the virus.

COVID-19 Virology Ott Lab